Sinovac Biotech Ltd (NASDAQ:SVA)

7.85
Delayed Data
As of 4:00pm ET
 -0.03 / -0.38%
Today’s Change
4.60
Today|||52-Week Range
8.75
-0.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues11.0M1.4M28.7M31.4M
 
 
 
 
 
Cost of Goods Sold3.2M2.3M4.5M7.4M
 
 
 
 
 
Depreciation And Amortization1.4M1.4M1.2M966.0K
 
 
 
 
 
 
Operating ExpensesGross Income6.3M-2.4M23.0M23.0M
 
 
 
 
 
General Expenses8.5M11.4M17.0M19.2M
 
 
 
 
 
Research And Development2.1M2.8M4.2M3.6M
 
 
 
 
 
Total Operating Expenses13.1M15.1M22.7M27.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.2M-13.7M6.0M3.9M
 
 
 
 
 
Interest Expense On Debt383.0K401.0K352.0K593.0K
 
 
 
 
 
Other Expenses646.0K-47.0K-1.0K6.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M-14.0M5.8M9.4M
 
 
 
 
 
Income Taxes-52.0K-1.4M-1.5M-2.6M
 
 
 
 
 
Minority Interest-560.0K-3.0M-1.1M-2.4M
 
 
 
 
 
Discontinued Operations2.3M0.000.000.00
 
 
Net Income1.3M-9.6M3.2M4.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS56.9M56.9M57.0M57.0M
 
 
 
 
 
Shares To Calculate EPS Diluted57.0M56.9M57.0M57.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.02-$0.17$0.06$0.08
 
 
 
 
 
EPS Diluted$0.02-$0.17$0.06$0.08